Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues. Reply to Nagel JM, Mansmann U, Wegscheider K et al. [letter] and Simon D [letter]
2009; Springer Science+Business Media; Volume: 53; Issue: 1 Linguagem: Inglês
10.1007/s00125-009-1582-6
ISSN1432-0428
AutoresUlrich Grouven, Lars G. Hemkens, Ralf Bender, P. T. Sawicki,
Tópico(s)Pancreatic function and diabetes
Referência(s)